| 发明名称 |
Treatment of cancer with dihydropyrazino-pyrazines |
| 摘要 |
Provided herein are methods for treating or preventing glioblastoma multiforme (GBM) characterized by 06-methylguanine-DNA methyltransferase (MGMT) expression and/or promoter methylation status, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound to a patient having glioblastoma multiforme (GBM) characterized by 06-methylguanine-DNA methyltransferase (MGMT) expression and/or promoter methylation status. |
| 申请公布号 |
AU2014254052(A1) |
申请公布日期 |
2015.10.29 |
| 申请号 |
AU20140254052 |
申请日期 |
2014.04.16 |
| 申请人 |
SIGNAL PHARMACEUTICALS, LLC |
发明人 |
RAYMON, HEATHER;HEGE, KRISTEN MAE |
| 分类号 |
A61K31/4985;A61P35/00 |
主分类号 |
A61K31/4985 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
